FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

john bennett

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Anatomy

Granulocyte Precursor Cells

Co-author Network

Publications

TOP 3
Pierre Fenaux; Ghulam J Mufti; Eva Hellstrom-Lindberg; Valeria Santini; Carlo Finelli; Aristoteles Giagounidis; Robert Schoch; Norbert Gattermann; Guillermo Sanz; Alan List; Steven D Gore; John F Seymour; john bennett; John Byrd; Jay Backstrom; Linda Zimmerman; David McKenzie; Cl Beach; Lewis R Silverman
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Robert Peter Gale; john bennett
Are myelodysplastic syndromes and acute myeloid leukemia one disease?
Denise M Oliansky; Joseph H Antin; john bennett; H Joachim Deeg; Christin Engelhardt; Kathleen V Heptinstall; Marcos de Lima; Steven D Gore; Ronald G Potts; Lewis R Silverman; Roy B Jones; Philip L McCarthy; Theresa Hahn
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of john bennett (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Pierre Fenaux; Ghulam J Mufti; Eva Hellstrom-Lindberg; Valeria Santini; Carlo Finelli; Aristoteles Giagounidis; Robert Schoch; Norbert Gattermann; Guillermo Sanz; Alan List; Steven D Gore; John F Seymour; john bennett; John Byrd; Jay Backstrom; Linda Zimmerman; David McKenzie; Cl Beach; Lewis R Silverman
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
The lancet oncology 2009;10(3):223-32.
2009: Robert Peter Gale; john bennett
Are myelodysplastic syndromes and acute myeloid leukemia one disease?
Leukemia research 2009;33(3):351-4.
2009: Denise M Oliansky; Joseph H Antin; john bennett; H Joachim Deeg; Christin Engelhardt; Kathleen V Heptinstall; Marcos de Lima; Steven D Gore; Ronald G Potts; Lewis R Silverman; Roy B Jones; Philip L McCarthy; Theresa Hahn
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(2):137-72.
2008: Ghulam J Mufti; john bennett; Jean Goasguen; Barbara J Bain; Irith Baumann; Richard Brunning; Mario Cazzola; Pierre Fenaux; Ulrich Germing; Eva Hellström-Lindberg; Itsuro Jinnai; Atsushi Manabe; Akira Matsuda; Charlotte M Niemeyer; Guillermo Sanz; Masao Tomonaga; Teresa Vallespi; Ayami Yoshimi
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.
Haematologica 2008;93(11):1712-7.
2008: john bennett
Consensus statement on iron overload in myelodysplastic syndromes.
American journal of hematology 2008;83(11):858-61.
2008: Ulrich Germing; Carlo Aul; Charlotte M Niemeyer; Rainer Haas; john bennett
Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes.
Annals of hematology 2008;87(9):691-9.
2007: Monica L Guzman; Randall M Rossi; Sundar Neelakantan; Xiaojie Li; Cheryl A Corbett; Duane C Hassane; Michael W Becker; john bennett; Edmund Sullivan; Joshua L Lachowicz; Andrew Vaughan; Christopher J Sweeney; William Matthews; Martin Carroll; Jane L Liesveld; Peter A Crooks; Craig T Jordan
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.
Blood 2007;110(13):4427-35.
2007: Gail J Roboz; john bennett; Morton Coleman; Ellen K Ritchie; Richard R Furman; Adrianna Rossi; Komal Jhaveri; Eric J Feldman; John P Leonard
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non-Hodgkin lymphoma.
Leukemia research 2007;31(8):1141-4.
2007: Ulrich Germing; Corinna Strupp; Sabine Knipp; Andrea Kuendgen; Aristoteles Giagounidis; Barbara Hildebrandt; Carlo Aul; Rainer Haas; Norbert Gattermann; john bennett
Chronic myelomonocytic leukemia in the light of the WHO proposals.
Haematologica 2007;92(7):974-7.
2007: P Fenaux; john bennett; D T Bowen; Robert D Knight; Alan F List
Evolving trends in the treatment of low-risk myelodysplastic syndromes: immunomodulation and beyond--9th European Hematology Association Congress Geneva, Switzerland, 10-13 June 2004.
Transfusion medicine (Oxford, England) 2007;17(3):151-60.
2007: Silvio Monfardini; M S Aapro; john bennett; M Mori; D Regenstreif; M Rodin; brian stein; G B Zulian; J P Droz
Organization of the clinical activity of geriatric oncology: report of a SIOG (International Society of Geriatric Oncology) task force.
Critical reviews in oncology/hematology 2007;62(1):62-73.
2007: john bennett
Aging, cancer, and anemia: intertwined and resolvable.
The journal of supportive oncology 2007;5(3):116-7.
2007: Shersten Killip; john bennett; Mara D Chambers
Iron deficiency anemia.
American family physician 2007;75(5):671-8.
2007: Ian W Flinn; Donna Neuberg; Michael R Grever; Gordon W Dewald; john bennett; Elisabeth Paietta; Mohamad A Hussein; Frederick R Appelbaum; Richard A Larson; Dennis F Moore; Martin S Tallman
Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(7):793-8.
2007: Richard T Silver; john bennett; J M Goldman; Jerry L Spivak; Ayalew Tefferi
The third International Congress on Myeloproliferative and Myelodysplastic Syndromes.
Leukemia research 2007;31(1):11-7.
2006: Marilyn L Slovak; Holly Gundacker; C D Bloomfield; G Dewald; Frederick R Appelbaum; R A Larson; Martin S Tallman; john bennett; Derek L Stirewalt; Soheil Meshinchi; Cheryl L Willman; Yaddanapudi Ravindranath; Todd A Alonzo; A J Carroll; S C Raimondi; Nyla A Heerema
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.
Leukemia 2006;20(7):1295-7.
2006: john bennett
Comment on flow-cytometric analysis of neutrophils.
American journal of hematology 2006;81(2):155.
2005: Janice P Dutcher; Sandra Lee; Robert E Gallagher; Adel Z Makary; John D Hines; Harold Londer; John P Farnen; john bennett; Elisabeth Paietta; Jacob M Rowe; Olga Goloubeva; Peter H Wiernik
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993).
Leukemia & lymphoma 2005;46(3):377-85.
2004: Richard T Silver; john bennett; Michael W N Deininger; Eric Feldman; Shahin Rafii; R L Silverstein; Lawrence Solberg; Jerry L Spivak
The second international congress on myeloproliferative and myelodysplastic syndromes.
Leukemia research 2004;28(9):979-85.
2003: Athena M Cherry; Stephanie R Brockman; Sarah F Paternoster; Gary A Hicks; Donna Neuberg; Rodney R Higgins; john bennett; Peter L Greenberg; Kenneth Miller; Martin S Tallman; Jacob Rowe; Gordon W Dewald
Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study.
Leukemia research 2003;27(12):1085-90.
2003: john bennett
Morphologic dysplasia in acute myeloid leukemia: importance of granulocytic dysplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):3004; author reply 3004-5.
2003: Arthur I Radin; Haesook T Kim; Barbara W Grant; john bennett; John M Kirkwood; James A Stewart; Richard G Hahn; Janice P Dutcher; Peter H Wiernik; Martin M Oken
Phase II study of alpha2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): a trial of the Eastern Cooperative Oncology Group.
Cancer 2003;98(1):100-9.
2003: john bennett
A brief commentary on "Refractory anemia with ring sideroblasts associated with i(17q) and mutation of the TP53 gene".
Cancer genetics and cytogenetics 2003;141(2):177.